Danaher Corporation $DHR Shares Sold by Payden & Rygel

Payden & Rygel lowered its holdings in Danaher Corporation (NYSE:DHR) by 97.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,000 shares of the conglomerate’s stock after selling 78,600 shares during the quarter. Payden & Rygel’s holdings in Danaher were worth $397,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Tyche Wealth Partners LLC purchased a new position in shares of Danaher during the 3rd quarter valued at approximately $462,000. Ceredex Value Advisors LLC grew its position in Danaher by 1.6% during the second quarter. Ceredex Value Advisors LLC now owns 249,377 shares of the conglomerate’s stock valued at $49,262,000 after buying an additional 3,862 shares during the period. Weitz Investment Management Inc. increased its holdings in Danaher by 6.1% in the second quarter. Weitz Investment Management Inc. now owns 526,950 shares of the conglomerate’s stock valued at $104,094,000 after buying an additional 30,300 shares in the last quarter. Lockheed Martin Investment Management Co. raised its position in shares of Danaher by 49.4% in the third quarter. Lockheed Martin Investment Management Co. now owns 25,340 shares of the conglomerate’s stock worth $5,024,000 after acquiring an additional 8,380 shares during the period. Finally, Nvwm LLC boosted its stake in shares of Danaher by 20.4% during the 2nd quarter. Nvwm LLC now owns 7,093 shares of the conglomerate’s stock worth $1,401,000 after acquiring an additional 1,204 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of NYSE:DHR opened at $209.56 on Monday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $242.80. The firm has a market capitalization of $148.02 billion, a PE ratio of 41.58, a P/E/G ratio of 2.83 and a beta of 0.91. The business’s 50 day moving average price is $226.85 and its 200-day moving average price is $216.03.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same quarter last year, the firm posted $2.14 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. As a group, equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a dividend of $0.32 per share. The ex-dividend date was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s payout ratio is presently 25.40%.

Analyst Ratings Changes

Several equities analysts recently weighed in on DHR shares. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. TD Cowen reissued a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. Robert W. Baird set a $251.00 target price on Danaher in a research note on Thursday, January 29th. Evercore reissued an “outperform” rating and issued a $254.00 price target on shares of Danaher in a research note on Wednesday, January 28th. Finally, KeyCorp reissued an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $253.86.

Insider Transactions at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.20% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.